• MLN2238: A Proteostasis Stress Probe

  2026-10-09

  MLN2238 is a proteasome β5 subunit inhibitor whose value extends beyond cytotoxicity assays. This article interprets its use as a mechanistic probe of proteotoxic stress, ROS/JNK signaling, and CRTC–CREB adaptation while defining the limits of translation from model systems to oncology research.

• Apigenin: Evidence, Scope and Limitations

  2026-10-09

  Apigenin is a plant-derived flavonoid studied in cellular models of neuroinflammation and cancer. This overview separates reported findings from mechanistic interpretation and explains why current evidence does not yet establish clinical efficacy.

• CRTC–CREB Sensing of Proteotoxic Stress in Drosophila

  2026-10-08

  A 2022 Cell Death and Disease study identified the CRTC–CREB axis as a stress-responsive transcriptional system activated by proteasome inhibition through ROS and JNK. Its findings connect proteostasis signaling with protein aggregation phenotypes in Drosophila, while also defining important limits for translation to mammalian disease and oncology models.

• Viral RIPK3 Degradation and Inflammation

  2026-10-08

  Liu and colleagues identified vIRD, a poxvirus factor that connects host SCF ubiquitin-ligase machinery to RIPK3 degradation, thereby suppressing necroptosis while shaping viral inflammation and pathogenesis. The study combines molecular, genetic, comparative virology, and mouse evidence to show how proteasome-linked turnover can influence virus–host evolution, while leaving important limits on generalization across viruses and disease models.

• SR 11302 and AP-1 Blockade in Cancer Research

  2026-10-07

  SR 11302 is described as a selective AP-1 transcription factor inhibitor with reported activity in cancer-cell and chemoprevention models. This overview compares those claims with findings from a 2024 colitis-associated colorectal cancer study, emphasizing evidence strength, mechanistic interpretation, and translational limits.

• L-NMMA Acetate and Nitric Oxide Signaling

  2026-10-07

  A source-grounded overview of L-NMMA acetate as a nitric oxide synthase research probe, centered on evidence from a rat dental follicle cell study of puerarin-driven osteogenic differentiation. The article separates reported findings from interpretation and outlines limits related to model choice, inhibitor selectivity, provenance, and translation.

• CA-074 and the Context of Cathepsin B Translation

  2026-10-06

  CA-074 is most informative when treated as a selective mechanistic probe rather than a universal disease-modifying agent. This thought-leadership analysis connects cathepsin B biology with cancer metastasis, neurodegeneration, immune response modulation, and the 2024 barley senescence study, while defining the evidence boundaries that matter for translational research.

• Z-LEHD-FMK: Five Questions on Apoptosis Evidence

  2026-10-05

  A source-grounded overview of what Z-LEHD-FMK can and cannot show in apoptosis research, using the reported Candida krusei–bovine mammary epithelial cell study to explain mechanism, evidence quality, interpretation and applicability limits.

• Antibiotic Use and Resistance in Psychiatric Hospitals

  2026-10-05

  This retrospective study examined antibacterial use and resistance patterns in a psychiatric hospital during the 2022 epidemic, combining hospital utilization metrics with microbiological surveillance. Its main contribution is a setting-specific view showing relatively low antibiotic use alongside substantial resistance concerns, supporting continued, data-driven stewardship rather than simple reliance on aggregate prescribing rates.

• SFRP1, Wnt Signaling, and Oral Submucous Fibrosis

  2026-10-03

  A 2024 mouse and cell study links reduced SFRP1 with neutrophil infiltration, fibrosis, and increased Wnt/β-catenin signaling in arecoline-induced oral submucous fibrosis. The findings support a mechanistic model in which SFRP1 may restrain inflammatory recruitment and fibrotic signaling, while also highlighting the limits of translating preclinical pathway observations into clinical treatment.

• Necrostatin-1 Workflows for RIP1 Kinase Research

  2026-10-02

  Build more interpretable necroptosis assays with Necrostatin-1, a selective RIP1 kinase inhibitor for pathway validation, inflammatory injury models, and host–pathogen experiments. This guide connects practical cell-based workflows with the cross-strain CRISPR findings of a Toxoplasma gondii virulence study.

• From Lactylation to Viability in ccRCC

  2026-10-01

  A translational framework for using Cell Counting Kit-8 (CCK-8) Plus to connect the AARS2–ULK1 lactylation axis with scalable viability, proliferation, cytotoxicity, and drug-response studies in clear cell renal cell carcinoma.

• Cyanidin Chloride for Oxidative Stress Assays

  2026-10-01

  Cyanidin Chloride supports integrated oxidative stress research that connects reactive oxygen species scavenging with inflammatory signaling and epithelial-barrier readouts. This workflow-focused guide shows how to handle the compound, build a defensible cell assay, and interpret evidence without conflating cyanidin chloride with the glycoside studied in a psoriasis model.

• Chloroquine Diphosphate: From Flux to Translation

  2026-09-30

  A mechanistic and translational guide to using Chloroquine Diphosphate as an autophagy perturbation tool, while separating lysosomal flux effects from cell-cycle arrest, innate immune signaling, and combination-treatment responses.

• Propidium Iodide: Reading Cell Death Precisely

  2026-09-30

  Propidium iodide is more than a red DNA stain: its signal reports both membrane access and nucleic-acid content. This guide develops a decision framework for cell viability assay, apoptosis detection, and cell-cycle analysis, with practical insight from an ATR–ALT cancer study.

7118 records 1/475 page Next 12345 下5页 Last page